Catalysts for Tufts Medical Center
4 tracked
Apr 30, 2026
phase 2 completion
Tufts Medical Center — phytonadione (Phase II Trial Completion)
PHYTONADIONE
→
Feb 9, 2026
grant
TUFTS MEDICAL CENTER — Pre- and post-exposure prophylaxis of tick-transmitted babesiosis by the anti...
Tufts Medical Center
→
Sep 30, 2025
grant
TUFTS MEDICAL CENTER — CE25-025 - Effectiveness of Paid Family and Medical Leave Policies and Policy...
Tufts Medical Center
→
Sep 15, 2025
grant
TUFTS MEDICAL CENTER — Targeting the Gut Mycobiome in Ulcerative Colitis
Tufts Medical Center
→